About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 3

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH

Longitudinal Clinical, Controlled, Randomized, Open-label, Phase III Study to Assess the Equivalence of Tranexamic Acid (TXA) vs Oxytocin (OXY) in Reducing Post Partum Haemorrhage (PPH) in Patients at the End of Pregnancy (37-42 w), at Low Risk of PPH

NCT02775773•Azienda U.S.L. 1 di Massa e Carrara

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Post Partum Haemorrhage

Interventions

Tranexamic Acid

Oxytocin

Locations

1

Italy

Locations (1)

Department of Ostetricia e Ginecologia-Ospedale delle Apuane

Massa, MS, Italy

Key Dates

Start Date

January 30, 2018

Primary Completion Date

December 31, 2018

Completion Date

December 31, 2018

Last Updated

February 8, 2024

Related Studies

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

NCT06655207

Post Partum HaemorrhageMaternal Care Patterns+1 more

TERMINATEDPhase 1

Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility

NCT02908126

Post Partum Haemorrhage

COMPLETEDPhase 3

Intramuscular Oxytocics: A Randomised Control Trial

NCT02216383

Post Partum Haemorrhage

Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy

NCT02900690

Health Care CostPost Partum Haemorrhage

COMPLETEDPhase 1/2

Evaluation of Melatonin's Effect on Pain and Blood Loss After Cesarean Section

NCT01572805

Post Partum Haemorrhage in Patients Undergoing Cesarean Section

Sponsors

Lead Sponsor

Azienda U.S.L. 1 di Massa e Carrara

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions